Monitor the site: Watch for any signs of infection (redness, swelling, warmth, or itching), irritation, or excessive pain at the injection site
Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
and get on the fountain of youth vitamins
This content does not constitute formal medical advice, a binding diagnosis, or a definitive treatment plan
Clinical & Experimental Metastasis
93% of type 2 diabetes mellitus patients were treated with ACEi, ARB, or ARNI (11%), 97% with beta-blocker, 71% with MRA, 95% with diuretic and 27% had an implantable device (with defibrillator function)